ONTAMALIMAB(-S) BLOCKS INFLAMMATORY BOWEL DISEASE T CELL ADHESION AND AMELIORATES T CELL-DEPENDENT COLITIS IN VIVO
Lisa Lou Schulze 1
Dan Sexton 2
Deborah Palliser 2
Markus F. Neurath 2
Sebastian Zundler 2
1 University of Erlangen-Nuremberg, Erlangen, Germany
2 Shire, a Takeda Company, Cambridge, United States
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]